Details for: GET3

Gene ID: 439

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: GET3

Ensembl ID: ENSG00000198356

Description: guided entry of tail-anchored proteins factor 3, ATPase

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • retinal ganglion cell CL0000740
    CSI 20.64
    rCSI 45.6%
    PRS 38.78
  • tracheobronchial smooth muscle cell CL0019019
    CSI 16.68
    rCSI 29.42%
    PRS 59.73
  • pancreatic ductal cell CL0002079
    CSI 14.54
    rCSI 28.29%
    PRS 53.81
  • bronchus fibroblast of lung CL2000093
    CSI 12.39
    rCSI 10.06%
    PRS 52.02
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 11.3
    rCSI 14.81%
    PRS 65.22
  • pancreatic A cell CL0000171
    CSI 11.25
    rCSI 11.78%
    PRS 54.7
  • respiratory suprabasal cell CL4033048
    CSI 10.15
    rCSI 13.02%
    PRS 56.36
  • pulmonary alveolar type 2 cell CL0002063
    CSI 9.15
    rCSI 14.19%
    PRS 60.25
  • lung secretory cell CL1000272
    CSI 8.94
    rCSI 22.14%
    PRS 49.37
  • retinal pigment epithelial cell CL0002586
    CSI 8.16
    rCSI 16.21%
    PRS 49.78
  • colon goblet cell CL0009039
    CSI 7.86
    rCSI 18.69%
    PRS 62.34
  • vascular associated smooth muscle cell CL0000359
    CSI 7.69
    rCSI 24.95%
    PRS 53.46
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 7.35
    rCSI 6.64%
    PRS 48.25
  • transit amplifying cell CL0009010
    CSI 5.74
    rCSI 8.78%
    PRS 67.14
  • alternatively activated macrophage CL0000890
    CSI 5.69
    rCSI 7.15%
    PRS 64.69
  • naive T cell CL0000898
    CSI 5.3
    rCSI 3.69%
    PRS 65.49
  • erythroid progenitor cell CL0000038
    CSI 5
    rCSI 28.65%
    PRS 62.06
  • retina horizontal cell CL0000745
    CSI 4.98
    rCSI 7.59%
    PRS 47.99
  • fallopian tube secretory epithelial cell CL4030006
    CSI 4.92
    rCSI 4.74%
    PRS 51.75
  • non-classical monocyte CL0000875
    CSI 4.78
    rCSI 7.66%
    PRS 77.49
  • alveolar macrophage CL0000583
    CSI 4.63
    rCSI 7.63%
    PRS 57
  • CD4-positive helper T cell CL0000492
    CSI 4.49
    rCSI 3.4%
    PRS 65.09
  • Cajal-Retzius cell CL0000695
    CSI 4.42
    rCSI 34.61%
    PRS 65.95
  • retinal cone cell CL0000573
    CSI 4.09
    rCSI 6.59%
    PRS 41.67
  • stem cell CL0000034
    CSI 3.7
    rCSI 3.57%
    PRS 42.03
  • early lymphoid progenitor CL0000936
    CSI 3.6
    rCSI 3.16%
    PRS 56.82
  • double negative thymocyte CL0002489
    CSI 3.48
    rCSI 2.42%
    PRS 61.54
  • epithelial cell of lower respiratory tract CL0002632
    CSI 3.45
    rCSI 2.68%
    PRS 52.26
  • intermediate monocyte CL0002393
    CSI 3.35
    rCSI 5.06%
    PRS 54.3
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 3.3
    rCSI 2.22%
    PRS 63.41
  • forebrain radial glial cell CL0013000
    CSI 3.29
    rCSI 10.55%
    PRS 58.15
  • primitive red blood cell CL0002355
    CSI 3.28
    rCSI 17.69%
    PRS 65.58
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 3.25
    rCSI 9.59%
    PRS 55.52
  • enteroendocrine cell CL0000164
    CSI 3.19
    rCSI 4.35%
    PRS 53.87
  • goblet cell CL0000160
    CSI 3.12
    rCSI 2.94%
    PRS 51.86
  • ON-bipolar cell CL0000749
    CSI 3.1
    rCSI 4.61%
    PRS 53.78
  • ciliated cell CL0000064
    CSI 3.09
    rCSI 5.01%
    PRS 49.21
  • erythrocyte CL0000232
    CSI 3.03
    rCSI 6.89%
    PRS 56.78
  • skin fibroblast CL0002620
    CSI 2.9
    rCSI 2.5%
    PRS 58.54
  • pancreatic stellate cell CL0002410
    CSI 2.81
    rCSI 16.38%
    PRS 61.68
  • extravillous trophoblast CL0008036
    CSI 2.66
    rCSI 3.29%
    PRS 47.35
  • erythroid lineage cell CL0000764
    CSI 2.62
    rCSI 16.85%
    PRS 72.02
  • neural progenitor cell CL0011020
    CSI 2.61
    rCSI 11.5%
    PRS 43.7
  • pro-B cell CL0000826
    CSI 2.61
    rCSI 2.16%
    PRS 52.99
  • plasmablast CL0000980
    CSI 2.61
    rCSI 2.05%
    PRS 58.12
  • mesodermal cell CL0000222
    CSI 2.59
    rCSI 3.11%
    PRS 49.4
  • pancreatic D cell CL0000173
    CSI 2.57
    rCSI 2.53%
    PRS 54.02
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 2.51
    rCSI 2.47%
    PRS 67.53
  • precursor B cell CL0000817
    CSI 2.48
    rCSI 2.17%
    PRS 61.62
  • perivascular cell CL4033054
    CSI 2.47
    rCSI 3.38%
    PRS 56.73
  • pulmonary ionocyte CL0017000
    CSI 2.47
    rCSI 3.01%
    PRS 59.38
  • intestinal epithelial cell CL0002563
    CSI 2.47
    rCSI 2.58%
    PRS 50.38
  • placental villous trophoblast CL2000060
    CSI 2.46
    rCSI 3.8%
    PRS 49.34
  • myofibroblast cell CL0000186
    CSI 2.45
    rCSI 3.4%
    PRS 54.76
  • interneuron CL0000099
    CSI 2.45
    rCSI 4.93%
    PRS 40.86
  • rod bipolar cell CL0000751
    CSI 2.42
    rCSI 4.35%
    PRS 44.74
  • fibroblast of lung CL0002553
    CSI 2.39
    rCSI 2.23%
    PRS 51.15
  • small pre-B-II cell CL0000954
    CSI 2.38
    rCSI 2.29%
    PRS 75.21
  • promyelocyte CL0000836
    CSI 2.33
    rCSI 3.36%
    PRS 61.33
  • radial glial cell CL0000681
    CSI 2.29
    rCSI 3.19%
    PRS 50.69
  • secretory cell CL0000151
    CSI 2.29
    rCSI 2.39%
    PRS 51.93
  • neural crest cell CL0011012
    CSI 2.26
    rCSI 1.79%
    PRS 38.69
  • elicited macrophage CL0000861
    CSI 2.26
    rCSI 2.08%
    PRS 59.85
  • T follicular helper cell CL0002038
    CSI 2.21
    rCSI 1.65%
    PRS 66.7
  • mucous neck cell CL0000651
    CSI 2.18
    rCSI 3.14%
    PRS 64.03
  • progenitor cell CL0011026
    CSI 2.14
    rCSI 4.55%
    PRS 53.51
  • mesenchymal cell CL0008019
    CSI 2.12
    rCSI 5.38%
    PRS 46.62
  • lung neuroendocrine cell CL1000223
    CSI 2.06
    rCSI 3.05%
    PRS 56.89
  • myeloid leukocyte CL0000766
    CSI 2.06
    rCSI 1.9%
    PRS 52.54
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 2.05
    rCSI 4.68%
    PRS 49.17
  • intestine goblet cell CL0019031
    CSI 2.03
    rCSI 1.8%
    PRS 49.97
  • ionocyte CL0005006
    CSI 2.02
    rCSI 2.17%
    PRS 49.82
  • interstitial cell of Cajal CL0002088
    CSI 2.02
    rCSI 2.57%
    PRS 57.4
  • epithelial cell CL0000066
    CSI 2.01
    rCSI 3.09%
    PRS 50.95
  • mammary gland epithelial cell CL0002327
    CSI 2.01
    rCSI 7.05%
    PRS 65.99
  • nasal mucosa goblet cell CL0002480
    CSI 2
    rCSI 2.32%
    PRS 60.87
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 1.98
    rCSI 1.17%
    PRS 68.1
  • alveolar adventitial fibroblast CL4028006
    CSI 1.97
    rCSI 3.1%
    PRS 52.69
  • duct epithelial cell CL0000068
    CSI 1.96
    rCSI 2.87%
    PRS 54.95
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 1.96
    rCSI 1.99%
    PRS 65.16
  • respiratory hillock cell CL4030023
    CSI 1.95
    rCSI 3.47%
    PRS 66.49
  • hematopoietic stem cell CL0000037
    CSI 1.94
    rCSI 1.29%
    PRS 55.22
  • ciliated epithelial cell CL0000067
    CSI 1.91
    rCSI 1.68%
    PRS 40.09
  • colon epithelial cell CL0011108
    CSI 1.87
    rCSI 1.95%
    PRS 48.42
  • acinar cell CL0000622
    CSI 1.85
    rCSI 2.71%
    PRS 62.97
  • mucus secreting cell CL0000319
    CSI 1.85
    rCSI 2.93%
    PRS 62.44
  • plasmacytoid dendritic cell, human CL0001058
    CSI 1.83
    rCSI 1.28%
    PRS 53.92
  • keratinocyte CL0000312
    CSI 1.83
    rCSI 1.53%
    PRS 56.47
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 1.76
    rCSI 2.04%
    PRS 45.38
  • basal cell CL0000646
    CSI 1.75
    rCSI 2.35%
    PRS 52.63
  • pancreatic acinar cell CL0002064
    CSI 1.74
    rCSI 2.31%
    PRS 56.9
  • conjunctival epithelial cell CL1000432
    CSI 1.73
    rCSI 2.65%
    PRS 52.16
  • multi-ciliated epithelial cell CL0005012
    CSI 1.72
    rCSI 1.72%
    PRS 45.29
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.65
    rCSI 1.27%
    PRS 50.81
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.63
    rCSI 1.49%
    PRS 66.2
  • mature B cell CL0000785
    CSI 1.62
    rCSI 1.41%
    PRS 61.87
  • peripheral nervous system neuron CL2000032
    CSI 1.61
    rCSI 2.2%
    PRS 44.29
  • mononuclear phagocyte CL0000113
    CSI 1.6
    rCSI 3.52%
    PRS 55.64
  • alveolar type 1 fibroblast cell CL4028004
    CSI 1.6
    rCSI 1.75%
    PRS 55.22
  • mature alpha-beta T cell CL0000791
    CSI 1.59
    rCSI 5.76%
    PRS 71.31
  • pre-conventional dendritic cell CL0002010
    CSI 0.1
    rCSI 1.6%
    PRS 82.2%
  • paneth cell of colon CL0009009
    CSI 0.2
    rCSI 2.0%
    PRS 73.6%
  • acinar cell of salivary gland CL0002623
    CSI 0.2
    rCSI 5.5%
    PRS 73.5%
  • respiratory goblet cell CL0002370
    CSI 0.3
    rCSI 3.1%
    PRS 69.9%
  • mesenchymal stem cell CL0000134
    CSI 0.4
    rCSI 4.0%
    PRS 66.5%
  • stromal cell of ovary CL0002132
    CSI 0.4
    rCSI 1.1%
    PRS 66.4%
  • bronchial goblet cell CL1000312
    CSI 0.5
    rCSI 2.0%
    PRS 71.0%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 0.5
    rCSI 1.5%
    PRS 53.5%
  • tracheobronchial serous cell CL0019001
    CSI 0.5
    rCSI 2.3%
    PRS 66.8%
  • deuterosomal cell CL4033044
    CSI 0.6
    rCSI 2.0%
    PRS 58.8%
  • podocyte CL0000653
    CSI 0.8
    rCSI 3.4%
    PRS 50.5%
  • common myeloid progenitor CL0000049
    CSI 0.8
    rCSI 0.7%
    PRS 52.5%
  • syncytiotrophoblast cell CL0000525
    CSI 0.9
    rCSI 2.5%
    PRS 67.8%
  • large pre-B-II cell CL0000957
    CSI 0.9
    rCSI 2.5%
    PRS 65.2%
  • pancreatic epsilon cell CL0005019
    CSI 1.0
    rCSI 4.4%
    PRS 72.6%
  • tracheal goblet cell CL1000329
    CSI 1.0
    rCSI 2.2%
    PRS 69.0%
  • lung macrophage CL1001603
    CSI 1.0
    rCSI 2.3%
    PRS 58.7%
  • respiratory basal cell CL0002633
    CSI 1.0
    rCSI 1.1%
    PRS 57.4%
  • glioblast CL0000030
    CSI 1.1
    rCSI 1.8%
    PRS 44.8%
  • lung pericyte CL0009089
    CSI 1.1
    rCSI 3.0%
    PRS 59.7%
  • club cell CL0000158
    CSI 1.2
    rCSI 1.8%
    PRS 49.5%
  • pancreatic PP cell CL0002275
    CSI 1.2
    rCSI 4.8%
    PRS 66.4%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.2
    rCSI 1.7%
    PRS 71.9%
  • M cell of gut CL0000682
    CSI 1.2
    rCSI 1.3%
    PRS 64.8%
  • Langerhans cell CL0000453
    CSI 1.2
    rCSI 1.9%
    PRS 68.6%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 1.2
    rCSI 6.1%
    PRS 63.5%
  • kidney epithelial cell CL0002518
    CSI 1.2
    rCSI 2.3%
    PRS 73.6%
  • type B pancreatic cell CL0000169
    CSI 1.2
    rCSI 2.7%
    PRS 49.1%
  • common dendritic progenitor CL0001029
    CSI 1.3
    rCSI 1.6%
    PRS 61.8%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 1.3
    rCSI 2.1%
    PRS 34.6%
  • foveolar cell of stomach CL0002179
    CSI 1.3
    rCSI 2.7%
    PRS 65.2%
  • dendritic cell, human CL0001056
    CSI 1.3
    rCSI 2.0%
    PRS 59.5%
  • lung ciliated cell CL1000271
    CSI 1.3
    rCSI 1.5%
    PRS 41.5%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 1.4
    rCSI 1.2%
    PRS 56.0%
  • retinal rod cell CL0000604
    CSI 1.4
    rCSI 2.5%
    PRS 49.1%
  • epithelial cell of proximal tubule CL0002306
    CSI 1.4
    rCSI 3.4%
    PRS 46.2%
  • muscle cell CL0000187
    CSI 1.4
    rCSI 2.9%
    PRS 72.1%
  • promonocyte CL0000559
    CSI 1.4
    rCSI 2.5%
    PRS 61.1%
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 1.4
    rCSI 1.9%
    PRS 49.3%
  • granulocyte CL0000094
    CSI 1.5
    rCSI 2.2%
    PRS 61.1%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.5
    rCSI 1.8%
    PRS 59.7%
  • epithelial cell of lung CL0000082
    CSI 1.5
    rCSI 1.2%
    PRS 50.3%
  • OFF-bipolar cell CL0000750
    CSI 1.5
    rCSI 2.0%
    PRS 60.6%
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 1.5
    rCSI 1.9%
    PRS 32.9%
  • group 3 innate lymphoid cell CL0001071
    CSI 1.5
    rCSI 1.1%
    PRS 55.8%
  • fraction A pre-pro B cell CL0002045
    CSI 1.5
    rCSI 1.7%
    PRS 73.2%
  • enteric smooth muscle cell CL0002504
    CSI 1.5
    rCSI 2.2%
    PRS 54.0%
  • colonocyte CL1000347
    CSI 1.6
    rCSI 2.3%
    PRS 57.5%
  • mature alpha-beta T cell CL0000791
    CSI 1.6
    rCSI 5.8%
    PRS 71.3%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 1.6
    rCSI 1.8%
    PRS 55.2%
  • mononuclear phagocyte CL0000113
    CSI 1.6
    rCSI 3.5%
    PRS 55.6%
  • peripheral nervous system neuron CL2000032
    CSI 1.6
    rCSI 2.2%
    PRS 44.3%
  • mature B cell CL0000785
    CSI 1.6
    rCSI 1.4%
    PRS 61.9%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.6
    rCSI 1.5%
    PRS 66.2%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.7
    rCSI 1.3%
    PRS 50.8%
  • multi-ciliated epithelial cell CL0005012
    CSI 1.7
    rCSI 1.7%
    PRS 45.3%
  • conjunctival epithelial cell CL1000432
    CSI 1.7
    rCSI 2.7%
    PRS 52.2%
  • pancreatic acinar cell CL0002064
    CSI 1.7
    rCSI 2.3%
    PRS 56.9%
  • basal cell CL0000646
    CSI 1.8
    rCSI 2.4%
    PRS 52.6%
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 1.8
    rCSI 2.0%
    PRS 45.4%
  • keratinocyte CL0000312
    CSI 1.8
    rCSI 1.5%
    PRS 56.5%
  • plasmacytoid dendritic cell, human CL0001058
    CSI 1.8
    rCSI 1.3%
    PRS 53.9%
  • mucus secreting cell CL0000319
    CSI 1.9
    rCSI 2.9%
    PRS 62.4%
  • acinar cell CL0000622
    CSI 1.9
    rCSI 2.7%
    PRS 63.0%
  • colon epithelial cell CL0011108
    CSI 1.9
    rCSI 2.0%
    PRS 48.4%
  • ciliated epithelial cell CL0000067
    CSI 1.9
    rCSI 1.7%
    PRS 40.1%
  • hematopoietic stem cell CL0000037
    CSI 1.9
    rCSI 1.3%
    PRS 55.2%
  • respiratory hillock cell CL4030023
    CSI 2.0
    rCSI 3.5%
    PRS 66.5%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.0
    rCSI 2.0%
    PRS 65.2%
  • duct epithelial cell CL0000068
    CSI 2.0
    rCSI 2.9%
    PRS 55.0%
  • alveolar adventitial fibroblast CL4028006
    CSI 2.0
    rCSI 3.1%
    PRS 52.7%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.0
    rCSI 1.2%
    PRS 68.1%
  • nasal mucosa goblet cell CL0002480
    CSI 2.0
    rCSI 2.3%
    PRS 60.9%
  • mammary gland epithelial cell CL0002327
    CSI 2.0
    rCSI 7.1%
    PRS 66.0%
  • epithelial cell CL0000066
    CSI 2.0
    rCSI 3.1%
    PRS 51.0%
  • interstitial cell of Cajal CL0002088
    CSI 2.0
    rCSI 2.6%
    PRS 57.4%
  • ionocyte CL0005006
    CSI 2.0
    rCSI 2.2%
    PRS 49.8%
  • intestine goblet cell CL0019031
    CSI 2.0
    rCSI 1.8%
    PRS 50.0%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 2.1
    rCSI 4.7%
    PRS 49.2%
  • myeloid leukocyte CL0000766
    CSI 2.1
    rCSI 1.9%
    PRS 52.5%
  • lung neuroendocrine cell CL1000223
    CSI 2.1
    rCSI 3.1%
    PRS 56.9%
  • mesenchymal cell CL0008019
    CSI 2.1
    rCSI 5.4%
    PRS 46.6%
  • progenitor cell CL0011026
    CSI 2.1
    rCSI 4.6%
    PRS 53.5%
  • mucous neck cell CL0000651
    CSI 2.2
    rCSI 3.1%
    PRS 64.0%
  • T follicular helper cell CL0002038
    CSI 2.2
    rCSI 1.7%
    PRS 66.7%
  • elicited macrophage CL0000861
    CSI 2.3
    rCSI 2.1%
    PRS 59.9%
  • neural crest cell CL0011012
    CSI 2.3
    rCSI 1.8%
    PRS 38.7%
  • secretory cell CL0000151
    CSI 2.3
    rCSI 2.4%
    PRS 51.9%
  • radial glial cell CL0000681
    CSI 2.3
    rCSI 3.2%
    PRS 50.7%
  • promyelocyte CL0000836
    CSI 2.3
    rCSI 3.4%
    PRS 61.3%
  • small pre-B-II cell CL0000954
    CSI 2.4
    rCSI 2.3%
    PRS 75.2%
  • fibroblast of lung CL0002553
    CSI 2.4
    rCSI 2.2%
    PRS 51.2%
  • rod bipolar cell CL0000751
    CSI 2.4
    rCSI 4.4%
    PRS 44.7%
  • interneuron CL0000099
    CSI 2.5
    rCSI 4.9%
    PRS 40.9%
  • myofibroblast cell CL0000186
    CSI 2.5
    rCSI 3.4%
    PRS 54.8%
  • placental villous trophoblast CL2000060
    CSI 2.5
    rCSI 3.8%
    PRS 49.3%
  • intestinal epithelial cell CL0002563
    CSI 2.5
    rCSI 2.6%
    PRS 50.4%
  • pulmonary ionocyte CL0017000
    CSI 2.5
    rCSI 3.0%
    PRS 59.4%
  • perivascular cell CL4033054
    CSI 2.5
    rCSI 3.4%
    PRS 56.7%
  • precursor B cell CL0000817
    CSI 2.5
    rCSI 2.2%
    PRS 61.6%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary **[GET3](/details-gene/439)** (guided entry of tail-anchored proteins factor 3, ATPase), also known as TRC40 or Asna1, is a cytosolic ATPase that plays a central role in cellular protein trafficking. It is a key component of the Guided Entry of Tail-anchored proteins (GET) pathway, which is responsible for the recognition and post-translational insertion of tail-anchored (TA) proteins into the endoplasmic reticulum membrane [[Link](https://doi.org/10.1016/j.cell.2007.01.036)], [[Link](https://doi.org/10.1016/j.molcel.2012.08.028)]. TA proteins are critical for a multitude of cellular functions, including vesicle trafficking, protein translocation, and apoptosis. The expression profile of **[GET3](/details-gene/439)** is widespread, but it shows particularly high significance in metabolically active and structurally complex cells such as the **[retinal ganglion cell](/details-cell/CL0000740)**, **[tracheobronchial smooth muscle cell](/details-cell/CL0019019)**, and **[pancreatic ductal cell](/details-cell/CL0002079)**, suggesting a high demand for its function in maintaining proteostasis in these specialized tissues. In addition to its role in protein insertion, it has also been identified as an arsenite-stimulated ATPase, implicating it in cellular responses to heavy metal stress [[Link](https://doi.org/10.1006/geno.1996.0494)], [[Link](https://doi.org/10.1074/jbc.273.35.22173)]. Association with disease has been noted, including its overexpression in certain cancers [[Link](https://doi.org/10.1177/002215549804601104)], and it is cataloged in OMIM as **[601913](https://omim.org/entry/601913)**. ## Cellular Roles and Expression Landscape The expression pattern of **[GET3](/details-gene/439)** underscores its fundamental housekeeping role in protein biogenesis, while also highlighting its elevated importance in specific cell lineages. **Overall**, the gene exhibits its highest significance in a diverse array of cell types characterized by high metabolic, secretory, or structural demands. The top-ranked cell, the **[retinal ganglion cell](/details-cell/CL0000740)** (CSI: 20.64), is a neuron with extensive axonal projections, likely requiring robust TA protein insertion to maintain its membrane integrity and signaling functions. High significance is also observed in contractile cells like **[tracheobronchial smooth muscle cell](/details-cell/CL0019019)** and **[vascular associated smooth muscle cell](/details-cell/CL0000359)**, as well as in various secretory and epithelial cells, including **[pancreatic ductal cell](/details-cell/CL0002079)**, **[pancreatic A cell](/details-cell/CL0000171)**, **[pulmonary alveolar type 2 cell](/details-cell/CL0002063)**, and **[colon goblet cell](/details-cell/CL0009039)**. This pattern is consistent with a critical need for **[GET3](/details-gene/439)** to manage the high flux of membrane proteins essential for ion transport, secretion, and maintaining cellular architecture in these tissues. Furthermore, its notable significance in immune cells like the **[CD14-positive, CD16-positive monocyte](/details-cell/CL0002397)** and in progenitor cells such as the **[megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050)** suggests that the GET pathway is integral to immune cell function and cellular differentiation. ## Pathways and Molecular Function The function of **[GET3](/details-gene/439)** is deeply rooted in fundamental cell biology, primarily protein targeting and localization. Its molecular activity is defined by **[ATP binding](/details-go/GO:0005524)** and subsequent **[ATP hydrolysis activity](/details-go/GO:0016887)**, which provides the energy to chaperone hydrophobic tail-anchored proteins through the aqueous cytosol and facilitate their insertion into the ER membrane. This core function is described by its involvement in the biological process of **[Tail-anchored membrane protein insertion into er membrane](/details-go/GO:0071816)** and is a central component of the Reactome pathway **[Insertion of tail-anchored proteins into the endoplasmic reticulum membrane](/details-pathway/R-HSA-9609523)**. As an integral part of the **[GET complex](/details-go/GO:0043529)**, **[GET3](/details-gene/439)** localizes to the **[cytoplasm](/details-go/GO:0005737)** where it recognizes its substrates and interacts with receptors like WRB on the **[endoplasmic reticulum membrane](/details-go/GO:0005789)** to complete the insertion process [[Link](https://doi.org/10.1242/jcs.084277)]. Interestingly, **[GET3](/details-gene/439)** also possesses **[Arsenite transmembrane transporter activity](/details-go/GO:0015105)** and is involved in **[Arsenite transport](/details-go/GO:0015700)**. This dual functionality suggests it may act at the intersection of protein homeostasis and cellular stress responses, potentially linking proteotoxic and chemical stress pathways. ## Research Directions The ubiquitous yet vital role of **[GET3](/details-gene/439)** in protein biogenesis, coupled with evidence of its dysregulation in disease, opens several avenues for future research. Early studies have indicated that **[GET3](/details-gene/439)** is overexpressed in breast adenomas and carcinomas, suggesting a potential role in oncogenesis [[Link](https://doi.org/10.1177/002215549804601104)]. ### Proposed Hypotheses: 1. **Oncogenic Dependency:** The elevated metabolic and proliferative rate of cancer cells creates a high demand for membrane proteins (e.g., signaling receptors, transporters). It is hypothesized that cancer cells become addicted to the **[GET3](/details-gene/439)** pathway to manage this increased proteomic load and avoid ER-stress-induced apoptosis. Therefore, targeting **[GET3](/details-gene/439)** could selectively impair the viability of tumor cells. 2. **Role in Neuroprotection:** Given its highest significance in **[retinal ganglion cells](/details-cell/CL0000740)**, it is hypothesized that **[GET3](/details-gene/439)** is critical for maintaining ER proteostasis and neuronal health in the central nervous system. A decline in **[GET3](/details-gene/439)** function with age or due to genetic factors could contribute to ER stress and sensitize neurons to degeneration, potentially playing a role in diseases like glaucoma or other optic neuropathies. 3. **Stress-Response Integration:** The dual function of **[GET3](/details-gene/439)** in protein insertion and arsenite transport suggests a hypothesis where it acts as a cellular stress sensor. Exposure to environmental toxins like arsenite may modulate its ATPase activity, thereby altering the insertion efficiency of specific TA proteins involved in stress mitigation or apoptosis, thus linking environmental exposure directly to cellular protein management. ### Experimental Approach: To test the hypothesis of oncogenic dependency (Hypothesis 1), a compelling experiment would be to use CRISPR-Cas9 to knock down or knock out **[GET3](/details-gene/439)** in a panel of breast cancer cell lines with varying endogenous expression levels. The impact on cell proliferation, survival, and cell cycle progression would be quantified. Mechanistically, the consequences of **[GET3](/details-gene/439)** loss on the ER-stress pathway could be evaluated by measuring the expression of key markers such as BiP, CHOP, and spliced XBP1 via qPCR and western blotting. A quantitative mass spectrometry approach could then identify the specific TA protein clients whose ER localization is most affected, potentially revealing key downstream effectors of **[GET3](/details-gene/439)**-driven cancer cell survival. ### Therapeutic Potential: As an ATPase, **[GET3](/details-gene/439)** belongs to a druggable class of enzymes, making it an attractive therapeutic target. The therapeutic strategy would focus on **inhibition**. The development of small molecule inhibitors that specifically target the ATP-binding pocket of **[GET3](/details-gene/439)** could disrupt the TA protein insertion pathway. Given its overexpression in tumors, such an inhibitor could create a synthetic lethal vulnerability in cancer cells that are highly dependent on this pathway for survival. The primary challenge would be to achieve a suitable therapeutic window, as **[GET3](/details-gene/439)** is also essential for healthy cells. However, the heightened proteomic stress in cancer cells may render them more sensitive to partial inhibition of the GET pathway than their normal counterparts.

Genular Protein ID: 3076587774

Symbol: GET3_HUMAN

Name: Transmembrane domain recognition complex 40 kDa ATPase subunit

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 15057824

Title: The DNA sequence and biology of human chromosome 19.

PubMed ID: 15057824

DOI: 10.1038/nature02399

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 8884272

Title: Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporter.

PubMed ID: 8884272

DOI: 10.1006/geno.1996.0494

PubMed ID: 9712828

Title: Biochemical characterization of the human arsenite-stimulated ATPase (hASNA-I).

PubMed ID: 9712828

DOI: 10.1074/jbc.273.35.22173

PubMed ID: 9736449

Title: Dual cytoplasmic and nuclear distribution of the novel arsenite-stimulated human ATPase (hASNA-I).

PubMed ID: 9736449

DOI: 10.1002/(sici)1097-4644(19981001)71:1<1::aid-jcb1>3.3.co;2-r

PubMed ID: 9774623

Title: Immunohistochemical analysis of the distribution of the human ATPase (hASNA-I) in normal tissues and its overexpression in breast adenomas and carcinomas.

PubMed ID: 9774623

DOI: 10.1177/002215549804601104

PubMed ID: 17382883

Title: Identification of a targeting factor for posttranslational membrane protein insertion into the ER.

PubMed ID: 17382883

DOI: 10.1016/j.cell.2007.01.036

PubMed ID: 18477612

Title: Distinct targeting pathways for the membrane insertion of tail-anchored (TA) proteins.

PubMed ID: 18477612

DOI: 10.1242/jcs.020321

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21444755

Title: WRB is the receptor for TRC40/Asna1-mediated insertion of tail-anchored proteins into the ER membrane.

PubMed ID: 21444755

DOI: 10.1242/jcs.084277

PubMed ID: 23041287

Title: Molecular machinery for insertion of tail-anchored membrane proteins into the endoplasmic reticulum membrane in mammalian cells.

PubMed ID: 23041287

DOI: 10.1016/j.molcel.2012.08.028

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 24392163

Title: WRB and CAML are necessary and sufficient to mediate tail-anchored protein targeting to the ER membrane.

PubMed ID: 24392163

DOI: 10.1371/journal.pone.0085033

PubMed ID: 25535373

Title: Bag6 complex contains a minimal tail-anchor-targeting module and a mock BAG domain.

PubMed ID: 25535373

DOI: 10.1073/pnas.1402745112

PubMed ID: 31461301

Title: Biallelic variants in ASNA1, encoding a cytosolic targeting factor of tail-anchored proteins, cause rapidly progressive pediatric cardiomyopathy.

PubMed ID: 31461301

DOI: 10.1161/circgen.119.002507

PubMed ID: 32910895

Title: Structural Basis of Tail-Anchored Membrane Protein Biogenesis by the GET Insertase Complex.

PubMed ID: 32910895

DOI: 10.1016/j.molcel.2020.08.012

Sequence Information:

  • Length: 348
  • Mass: 38793
  • Checksum: DA52C4ACC35C7A36
  • Sequence:
  • MAAGVAGWGV EAEEFEDAPD VEPLEPTLSN IIEQRSLKWI FVGGKGGVGK TTCSCSLAVQ 
    LSKGRESVLI ISTDPAHNIS DAFDQKFSKV PTKVKGYDNL FAMEIDPSLG VAELPDEFFE 
    EDNMLSMGKK MMQEAMSAFP GIDEAMSYAE VMRLVKGMNF SVVVFDTAPT GHTLRLLNFP 
    TIVERGLGRL MQIKNQISPF ISQMCNMLGL GDMNADQLAS KLEETLPVIR SVSEQFKDPE 
    QTTFICVCIA EFLSLYETER LIQELAKCKI DTHNIIVNQL VFPDPEKPCK MCEARHKIQA 
    KYLDQMEDLY EDFHIVKLPL LPHEVRGADK VNTFSALLLE PYKPPSAQ